Fleet Laboratories
Fleet Laboratories Ltd are part of the DDD Group of Companies which was established in 1912 and is still privately owned. We work with customers in the health and beauty industry manufacturing pharmaceutical products on behalf of the licence holder and developing and manufacturing toiletry products for both brand owners and retailers. We have a diverse range of customers, some of whom we have worked with for nearly 30 years. Depending on your business need, we have a flexible range of services available.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Company Details
Latest Content from PMHub
Mtech Access host transforming healthcare symposium
Press Releases | August 7, 2024 | Petauri Evidence
• Mtech Access are once again hosting a symposium looking at transforming the healthcare landscape in the UK and how to foster NHS–industry collaboration • Guest speakers from across the...
Caring for patients’ mental health in clinical trials
White Papers and Resources | August 6, 2024 | Cuttsy + Cuttsy
We look at why ensuring continuous mental health support for patients in clinical trials is essential to enhance their overall well-being and trial engagement.
The value of medical education in driving commercial success
White Papers and Resources | August 6, 2024 | Onyx Health
Onyx Health's Sarah Seilly discusses how innovative, data-driven approaches to medical education and strategic collaborations with HCPs can drive engagement and ensure commercial success in an evolving healthcare industry.
[Free Whitepaper] 6 reasons why direct patient support is a ‘must have’ for your clinical trials
White Papers and Resources | August 5, 2024 | Innovative Trials
This white paper explores the importance of patient-first services and why direct patient support is crucial for the success of sponsors’ clinical trials. Download it for FREE 👉🏽 https://innovativetrials.com/six-reasons-why-direct-patient-support-is-a-must-have-for-your-clinical-trials/
Assessing opportunities for manufacturers to communicate the value of therapies to oncology clinical pathway (OCP) developers
White Papers and Resources | August 5, 2024 | Genesis Research Group
Based on insights from 15 U.S. payers and providers, this white paper explores how manufacturers can effectively engage oncology clinical pathway (OCP) developers.
Leading the Way at ESC 2024
Press Releases | August 5, 2024 | Medscape Education
Anticipation is building at Medscape Education as the team prepares for the ESC 2024 Congress. We are excited to announce a significant presence during the congress including a booth (#H500)...
Driving equitable healthcare: The role of DE&I in clinical trials
White Papers and Resources | August 5, 2024 | Cuttsy + Cuttsy
Diversity, equity and inclusion (DE&I) is becoming a bigger topic of conversation and meaningful action within clinical trials. And for good reason, too. Find out why we embrace this and...
Uniting Communities for Rare Disease Clinical Trial Success
Videos and Podcasts | August 2, 2024 | Innovative Trials
Step into the realm of innovation and collaboration in patient recruitment and retention with our upcoming webinar, "Bridging Boundaries: Uniting Communities for Rare Disease Clinical Trial Success." Delve deep into...
Patient Recruitment & Retention Strategies in the 2024 Clinical Trial Landscape
Videos and Podcasts | August 2, 2024 | Innovative Trials
In the landscape of the clinical trial industry in 2024, persistent challenges persist in the realms of patient recruitment and retention. These hurdles, having endured over several years, continue to...
Solving your biggest patient recruitment and retention challenges
Videos and Podcasts | August 2, 2024 | Innovative Trials
Clinical trial patient recruitment and retention remains one of the key challenges to successfully bringing a new therapeutic to market. An estimated 85% of clinical trials face delays due to...